Antisense oligonucleotides targeting lncRNA AC104041.1 induces antitumor activity through Wnt2B/β-catenin pathway in head and neck squamous cell carcinomas

Abstract

Long non-coding RNAs (lncRNAs) contribute to the initiation and progression of various tumors, including head and neck squamous carcinoma (HNSCC), which is a common malignancy with high morbidity and low survival rate. However, the mechanism of lncRNAs in HNSCC tumorigenesis remains largely unexplored. In this work, we identified a novel lncRNA AC104041.1 which is highly upregulated and correlated with poor survival in HNSCC patients. Moreover, AC104041.1 overexpression significantly promoted tumor growth and metastasis of HNSCC in vitro and in vivo. Mechanistically, AC104041.1 mainly located in the cytoplasm and could function as ceRNA (competing endogenous RNA) for miR-6817-3p, thereby stabilized Wnt2B, and consequently inducing β-catenin nuclear translocation and activation. Moreover, we demonstrate that salinomycin, which as a highly effective antibiotic in the elimination of cancer stem cells through the Wnt/β-catenin signaling, could enhance the inhibition of tumor growth by antisense oligonucleotides (ASO) targeting AC104041.1 in HNSCC cells and PDXs (patient-derived xenograft) model. Thus, our data provide preclinical evidence to support a novel strategy of ASOs targeting AC104041.1 in combination with salinomycin and may as a beneficial treatment approach for HNSCC.

PiRNA-63049 inhibits bone formation through Wnt/β-catenin signaling pathway

“…Preliminary studies have shown that Wnt2b is a highly conserved member of the WNT family [48]. Wnt2b was found dysregulated in several cancers with aberrant Wnt/β-catenin pathway activity [49][50][51][52][53]. In our study, we identified that Wnt2b is positively associated with osteogenesis by activating the Wnt/β-catenin signaling pathway for the first time.…”

<p>Knockdown of lncRNA ABHD11-AS1 Suppresses the Tumorigenesis of Pancreatic Cancer via Sponging miR-1231</p>

“…It has been confirmed that miRNAs could exert their biological function mainly by binding their target mRNAs. 30,31 In the current study, we found cyclin E1 was a direct target of miR-1231, which has been regarded as a key regulator in cell cycle. 32 In addition, CDK2 was found to be downregulated in pancreatic cancer cells in the presence of ABHD11-AS1 shRNA1.…”

DNA methylation integratedly modulates the expression of Pit-Oct-Unt transcription factors in esophageal squamous cell carcinoma

“…The cell lines may not reflect the actual condition of the cells in the patient's tumor tissue [44]. A feasible strategy to solve this problem is to obtain and use PDCs, and there have been many reports on related studies [45][46][47][48]. Our research not only used three ESCC cell lines, but also established patient-derived cell lines as a supplement.…”